1. Sullivan M: The new subjective medicine: taking the patient’s point of view on health care and health. Soc Sci Med 2003,56(7):1595–1604. 10.1016/S0277-9536(02)00159-4
2. Committee for Medicinal Products for Human Use: Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products: European Medicines Agency; 2005. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdf
3. U.S. Department of Health and Human Services, Food and Drug Administration: Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. Washington, DC; 2009. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf
4. Blankenship JC, Marshall JJ, Pinto DS, Lange RA, Bates ER, Holper EM, Grines CL, Chambers CE: Effect of percutaneous coronary intervention on quality of life: a consensus statement from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 2013,81(2):243–259. 10.1002/ccd.24376
5. Höfer S, Lim L, Guyatt G, Oldridge NB: The MacNew heart disease health-related quality of life instrument: a summary. Health Qual Life Out 2004,2(3):10–1186.